We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Illustration

New Recombinant Hyperimmune Drug Class Offers 100-Fold Higher Potency than Convalescent Serum Therapy for COVID-19

A new class of polyclonal antibody drugs, termed recombinant hyperimmunes, which comprise thousands to tens of thousands of antibodies, could be much more powerful than convalescent serum therapies that have been touted as a unique and viable way to address the ongoing COVID-19 pandemic. More...
11 Aug 2020
Illustration

New COVID-19 Mobile Testing Device Diagnoses Infection Immediately via Breath Sample Using AI

Scientists have developed a medical device that has the potential to allow public health professionals to immediately diagnose COVID-19 infection via breath sample and track through a mobile device without the need for saliva or blood samples. More...
11 Aug 2020
Illustration

Oral COVID-19 Vaccine Could Activate both Systemic and Mucosal Immunity for Protection against Coronavirus

Vaxart, Inc. (South San Francisco, CA, USA) has further advanced its oral COVID-19 vaccine candidate towards the clinic by filing its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA). More...
11 Aug 2020
Illustration

Thermo Fisher Develops New COVID-19 Antibody Assay Targeting Transplant Community

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has developed a new serological assay targeted towards transplant candidates and recipients that can detect antibodies directed against COVID-19 (SARS-CoV-2). More...
11 Aug 2020
Illustration

Helix COVID-19 NGS Test One of the First Sequencing-Based COVID-19 Tests To Secure FDA Emergency Use Authorization

Helix (San Mateo, CA, USA) has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for the Helix COVID-19 NGS Test, making it one of the first sequencing-based COVID-19 tests to be granted FDA EUA. More...
11 Aug 2020
Illustration

AI Technology Detects Deterioration in COVID-19 Patients by Identifying Predictive Patterns in Their Vital Signs

A new study will apply Artificial Intelligence (AI) technology to look for predictive patterns in the vital signs of COVID-19 patients that could alert the medical team about any deterioration. More...
11 Aug 2020
Dr. Bill Groutas, Wichita State University

Newly-Engineered Antiviral Compounds Can Neutralize SARS-CoV-2 in Human Airway Cells

A team of virologists from the Wichita State University (Wichita, KS, USA) has published a study revealing how molecule protease inhibitors show potency against human coronaviruses, paving the way for a possible therapeutic treatment for COVID-19. More...
11 Aug 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.